García-Foncillas, Jesús
Argente, Jesús
Bujanda, Luis
Cardona, Victoria
Casanova, Bonaventura
Fernández-Montes, Ana
Horcajadas, José A.
Iñiguez, Andrés
Ortiz, Alberto
Pablos, José L.
Pérez Gómez, María Vanessa
Funding for this research was provided by:
Cátedra UAM–Merck
Article History
Accepted: 4 July 2021
First Online: 30 July 2021
Declarations
:
: Professional medical writing was funded by the Cátedra UAM–Merck in Molecular Individualized Medicine.
: J.G.F discloses consulting/advisory/honoraria speaker roles with Abbott, Amgen, Astellas, Astra Zeneca, Biocartis, Boehringer Ingelheim, BMS, Bayer, Celgene, Eisai, Foundation Medicine, GSK, Hospira, Janssen, Lilly, Merck Serono, MSD, Novartis, Pharmamar, Pfizer, Roche, Sanofi, Servier, Sysmex, and Tesaro. J.A. has received research grants from the Spanish Ministry of Science and Innovation with the help of European FEDER funding (FIS PI19/00166), and the Network Center for Biomedical Research on Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III. A.O. is a consultant for Sanofi Genzyme and has received speaker fees or travel support from AstraZeneca, Amicus, Amgen, Fresenius Medical Care, Menarini, Kyowa Kirin, Alexion, Otsuka, and Vifor Fresenius Medical Care Renal Pharma, and is Director of the Cátedra Mundipharma–UAM of diabetic kidney disease. A.O. has also received research grants from FIS/Fondos FEDER (PI17/00257, PI18/01386, PI19/00588, PI19/00815, DTS18/00032), ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071), ISCIII-RETIC (REDinREN RD016/0009), Sociedad Española de Nefrología, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. V.C. reports personal fees from ALK, Allergy Therapeutics, LETI, Thermofisher, Merck, AstraZeneca, and GSK, outside the submitted work. B.C. declares that the Neuroimmunology Unit has received grants from: Biogen-Idec, Sanofi-Genzyme, Merck-Serono, Celgene-BMS, Almirall, Roche, and TEVA, and he has received consulting fees from Sanofi-Genzyme, Merck-Serono and Celgene-BMS. A.F.M. discloses consulting/advisory/speaker honoraria from Kyowa Kirin, Eisai, Servier, Amgen, Sanofi, Bayer, Lilly, BMS, Roche, and Merck. M.V.P.G. is a consultant for Sanofi Genzyme and has received speaker fees or travel support from AstraZeneca, Amicus, Amgen, Fresenius Medical Care, Menarini, Kyowa Kirin, Alexion, Otsuka, and Vifor Fresenius Medical Care Renal Pharma, and is Director of the Cátedra Mundipharma–UAM of diabetic kidney disease. She has also received research grants from FIS/Fondos FEDER (PI17/00257, PI18/01386, PI19/00588, PI19/00815, DTS18/00032), ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071), ISCIII-RETIC (REDinREN RD016/0009), Sociedad Española de Nefrología, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. L.B., J.A.H., and A.I have nothing to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: All named authors meet the International Committee of Medical Journal Editors’ criteria for authorship for this article. All authors read and approved the final manuscript.